150 related articles for article (PubMed ID: 23771850)
1. Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine.
Xu M; Zhou L; Zhang P; Lu Y; Ge C; Yao W; Xing Y; Xiao W; Dong Y; Wu J; Cao R; Li T
Tumour Biol; 2013 Oct; 34(5):3173-82. PubMed ID: 23771850
[TBL] [Abstract][Full Text] [Related]
2. A Fixed Human Umbilical Vein Endothelial Cell Vaccine With 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407-426 As Adjuvant for Therapy of Hepatoma in Mice.
Xu M; Zhou L; Zhang Y; Xie Z; Zhang J; Guo L; Wang C; Yang X
J Immunother; 2015 Sep; 38(7):276-84. PubMed ID: 26261891
[TBL] [Abstract][Full Text] [Related]
3. Two tandem repeats of mHSP70
Xu M; Zhang Y; Dong W; Jiang L; Zhang J; Yu P; Xie S; Zhou L
Life Sci; 2018 May; 201():102-110. PubMed ID: 29572180
[TBL] [Abstract][Full Text] [Related]
4. Assessment of in vivo anti-tumor activity of human umbilical vein endothelial cell vaccines prepared by various antigen forms.
Zhou L; Si C; Li D; Lu M; Zhong W; Xie Z; Guo L; Zhang S; Xu M
Eur J Pharm Sci; 2018 Mar; 114():228-237. PubMed ID: 29277666
[TBL] [Abstract][Full Text] [Related]
5. Low-dose docetaxel enhances the anti-tumour efficacy of a human umbilical vein endothelial cell vaccine.
Zhou L; Lu M; Zhong W; Yang J; Yin Y; Li M; Li D; Zhang S; Xu M
Eur J Pharm Sci; 2020 Jan; 142():105163. PubMed ID: 31756447
[TBL] [Abstract][Full Text] [Related]
6. Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.
Ge C; Xing Y; Wang Q; Xiao W; Lu Y; Hu X; Gao Z; Xu M; Ma Y; Cao R; Liu J
Int Immunopharmacol; 2011 Dec; 11(12):2200-7. PubMed ID: 22015603
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical vein endothelial cell vaccine suppresses the angiogenesis of esophageal squamous cell carcinoma in a humanized mouse model.
Liu H; Zhao J; Yang Y; Jin G; Zhang X; Wang D; Xie C; Liu K; Chen X; Li X; Tian F; Dong Z; Lu J
Oncol Rep; 2018 Nov; 40(5):3006-3014. PubMed ID: 30132560
[TBL] [Abstract][Full Text] [Related]
9. Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.
Xu M; Xing Y; Zhou L; Yang X; Yao W; Xiao W; Ge C; Ma Y; Yang J; Wu J; Cao R; Li T; Liu J
Tumour Biol; 2013 Jun; 34(3):1399-408. PubMed ID: 23456765
[TBL] [Abstract][Full Text] [Related]
10. Improved Antitumor Efficacy of Combined Vaccine Based on the Induced HUVECs and DC-CT26 Against Colorectal Carcinoma.
Zhang Q; Xie C; Wang D; Yang Y; Liu H; Liu K; Zhao J; Chen X; Zhang X; Yang W; Li X; Tian F; Dong Z; Lu J
Cells; 2019 May; 8(5):. PubMed ID: 31121964
[TBL] [Abstract][Full Text] [Related]
11. Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models.
Wang ZY; Xing Y; Liu B; Lu L; Huang X; Ge CY; Yao WJ; Xu ML; Gao ZQ; Cao RY; Wu J; Li TM; Liu JJ
Chin J Cancer; 2012 Jun; 31(6):295-305. PubMed ID: 22464650
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
[TBL] [Abstract][Full Text] [Related]
13. A tumor lysate is an effective vaccine antigen for the stimulation of CD4(+) T-cell function and subsequent induction of antitumor immunity mediated by CD8(+) T cells.
Kawahara M; Takaku H
Cancer Biol Ther; 2015; 16(11):1616-25. PubMed ID: 26391871
[TBL] [Abstract][Full Text] [Related]
14. Fusion with human lung cancer cells elongates the life span of human umbilical endothelial cells and enhances the anti-tumor immunity.
Mu X; Fang C; Zhou J; Xi Y; Zhang L; Wei Y; Yi T; Wu Y; Zhao X
J Cancer Res Clin Oncol; 2016 Jan; 142(1):111-23. PubMed ID: 26139353
[TBL] [Abstract][Full Text] [Related]
15. Efficacy for lung metastasis induced by the allogeneic bEnd3 vaccine in mice.
Zhao J; Lu J; Zhou L; Zhao J; Dong Z
Hum Vaccin Immunother; 2018 May; 14(5):1294-1304. PubMed ID: 29360423
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of hepatocellular carcinoma by DNA shuffling-based VEGF vaccine and doxorubicin.
Li Z; Ding J; Zhao X; Qi G
Immunotherapy; 2018 Aug; 10(11):951-969. PubMed ID: 30114953
[TBL] [Abstract][Full Text] [Related]
17. [Nanogold inhibits angiogenesis and growth of liver cancer: experiment with mice].
Pan YL; Qiu SY; Qin L; Cai JY; Sun JS
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):800-4. PubMed ID: 19595116
[TBL] [Abstract][Full Text] [Related]
18. Combined endostatin and TRAIL gene transfer suppresses human hepatocellular carcinoma growth and angiogenesis in nude mice.
Zhang Y; Qu ZH; Cui M; Guo C; Zhang XM; Ma CH; Sun WS
Cancer Biol Ther; 2009 Mar; 8(5):466-73. PubMed ID: 19223770
[TBL] [Abstract][Full Text] [Related]
19. Microbial HSP70 peptide epitope 407-426 as adjuvant in tumor-derived autophagosome vaccine therapy of mouse lung cancer.
Li J; Xing Y; Zhou Z; Yao W; Cao R; Li T; Xu M; Wu J
Tumour Biol; 2016 Nov; 37(11):15097-15105. PubMed ID: 27662838
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomas.
Bai XL; Zhang Q; Ye LY; Hu QD; Fu QH; Zhi X; Su W; Su RG; Ma T; Chen W; Xie SZ; Chen CL; Liang TB
Mol Cancer Ther; 2014 Aug; 13(8):2062-72. PubMed ID: 24867249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
